Mary Sue Wilson Coleman was born on October 2, 1943, in Madison County, Kentucky. Her family later moved to Cedar Falls, Iowa, where her father, Leland Wilson, taught chemistry at what is now the University of Northern Iowa. She attended a laboratory school connected to that campus and graduated from high school in Cedar Falls. Early science-fair work already pointed toward research. She competed in the International Science and Engineering Fair and the Westinghouse Science Talent Search, with a project on bacterial resistance to penicillin. Those experiences, she later said, convinced her she could compete at a high level in science.
She earned a bachelor’s degree in chemistry from Grinnell College in 1965 and a doctorate in biochemistry from the University of North Carolina at Chapel Hill in 1969, with postdoctoral work at North Carolina and at the University of Texas at Austin. In 1969 she joined the biochemistry faculty at the University of Kentucky, where she remained for nineteen years. Her laboratory work centered on the immune system and on malignancies. She also served as a Cancer Center administrator and sat on review panels for the National Institutes of Health and the National Science Foundation, and on the editorial board of the Journal of Biological Chemistry. The path was not crowded with women. At Grinnell she had women classmates in chemistry but no women professors in the field, a gap she later treated as a problem to measure and correct rather than a private inconvenience.
Administration came in stages. In 1990 she became associate provost and dean of research at the University of North Carolina at Chapel Hill, then vice chancellor for graduate studies and research. From 1993 to 1995 she was provost and vice president for academic affairs at the University of New Mexico. In 1995 the University of Iowa named her its eighteenth president, the first woman to hold the office. She also held faculty appointments in biochemistry and biological sciences. Iowa’s research budget and annual fund-raising roughly doubled during her seven years, even as state budgets tightened, and she oversaw construction across liberal arts, medicine, engineering, biology, the arts, and athletics. She joined the Meredith Corporation board in 1997.
In August 2002 she became the thirteenth president of the University of Michigan, again with faculty appointments in biological chemistry and chemistry. The appointment placed her at the center of a national fight over race-conscious admissions. Michigan’s undergraduate and law-school policies were before the U.S. Supreme Court in Grutter v. Bollinger and Gratz v. Bollinger, decided in 2003. The Court upheld the law school’s holistic use of race as one factor and struck down the undergraduate point system. Coleman defended the educational value of a diverse student body throughout the litigation and in the years that followed, arguing that classrooms and research groups were stronger when they drew on varied backgrounds. Later restrictions on affirmative action, including the 2006 Michigan ballot initiative and the Court’s eventual rejection of race-conscious admissions, reshaped the policies she had defended, but the cases remain the clearest public record of her view that access and excellence were linked.
Her Michigan presidency, which ran until 2014, was also a building and fund-raising presidency. The Michigan Difference campaign, launched in 2004, raised $3.2 billion, then a record for a public university. Research spending rose sharply. Dozens of new degree programs were added, and a large number of buildings were constructed or substantially renovated, among them work tied to the Life Sciences Institute and the later North Campus Research Complex, acquired from Pfizer. A partnership with Google began the digitization of the university’s roughly seven-million-volume library, an early large-scale effort to put a major research collection online. She pushed residential-life changes meant to tie living arrangements more closely to academic work, and she helped form the University Research Corridor with Michigan State and Wayne State as a vehicle for economic development inside the state. International agreements linked Michigan with universities in China, Ghana, South Africa, Brazil, and India. In 2009 Time magazine placed her among the ten best college presidents in the country, citing fund-raising and the emphasis on research. In 2010 she was named co-chair of the National Advisory Council on Innovation and Entrepreneurship and was enlisted in the Obama administration’s Advanced Manufacturing Partnership. She served on the Johnson & Johnson board from 2003.
After leaving the Michigan presidency she became president of the Association of American Universities, serving from 2016 to 2020. The AAU represents the leading American research universities. Under her tenure the association conducted large surveys of students on sexual assault and misconduct, covering more than 180,000 respondents at dozens of campuses, and used the results to press member institutions on prevention and response. She continued to speak on access to higher education and on the place of women in the professoriate, returning to analyses she had begun years earlier at North Carolina about the slow growth in the number of women faculty.
In January 2022 she returned to Ann Arbor as interim president of the University of Michigan after the resignation of Mark Schlissel, serving until October of that year and then resuming emerita status. Honors accumulated across the career: election to the Institute of Medicine (now the National Academy of Medicine) in 1997, fellowship in the American Association for the Advancement of Science, election to the American Academy of Arts and Sciences in 2001, and a Lifetime Achievement Award from the American Council on Education in 2014.
She is married to Kenneth Coleman, a political scientist whose work focuses on Latin America. They have one son. The public record of her career is the record of a biochemist who moved into the senior ranks of public research universities at a moment when those institutions were expanding their scientific ambitions, defending selective admissions in court, digitizing their libraries, and tying their growth to regional economies. Supporters point to the fund-raising totals, the research growth, and the defense of diversity as educational policy. Critics of the affirmative-action cases, and of large presidential compensation and corporate board service by university leaders, have used her tenure as an example in broader arguments about public universities. The measurable institutional changes at Iowa and Michigan, and the court record from 2003, remain the concrete basis on which those arguments rest.